Retrospective Analysis of Linagliptin Data in Sub-Populations With Type 2 …

Published May 6, 2013

Retrospective analysis of linagliptin data in sub-populations with type 2 …

Filed under: drug treatment programs in maryland

"Response to treatment can vary between sub-populations of adults with type 2 diabetes," said Christophe Arbet-Engels, MD, PhD, vice president, clinical development and medical affairs metabolic, Boehringer Ingelheim Pharmaceuticals, Inc. "Those with …
Read more on MarketWatch (press release)

Viviscal Presents Supplements for First Time at World Hair Congress

Filed under: drug treatment programs in maryland

Viviscal showcased the renowned Hair Growth Program and presented their recent clinical study supporting the product efficacy, with distinguished, board certified dermatologist and cosmetic surgeon Dr. Glynis Ablon, MD, FAAD. Dr. Ablon shared results …
Read more on Wall Street Journal (press release)

Nymox Reports on Symposium and Panel Discussion on NX-1207 at American …

Filed under: drug treatment programs in maryland

HASBROUCK HEIGHTS, N.J., May 6, 2013 (GLOBE NEWSWIRE) — Nymox Pharmaceutical Corporation (Nasdaq:NYMX) is pleased to report on the presentation on NX-1207 drug studies at a high-level symposium and panel discussion held at the Annual Meeting of the …
Read more on Wall Street Journal (press release)